Oligonucleotide phosphonates and method of inhibiting a human im

Details Oligonucleotide phosphonates and method of inhibiting a human im Oligonucleotide phosphonates and method of inhibiting a human im

1987-07-14

1992-05-05

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 27, 536 28, 536 29, 435 6, A61K 3170

Patent

active

051108020

ABSTRACT:
A method of inhibiting human immunodeficiency virus (HIV) comprising administering a therapeutically effective amount of an antiviral agent to attack the first splice acceptor site of the tat III gene of HIV.

REFERENCES:
patent: 4469863 (1984-09-01), Ts'O et al.
Guyadet et al., Nature, vol. 326, pp. 662-669, 1987.
Arya et al., P.N.A.S. USA, vol. 83, pp. 2209-2213, 1986.
Alizon et al., Cell, vol. 46, pp. 63-74, 1986.
Barone et al., J. of Immunology, vol. 137(2), pp. 669-673, 1986.
Sandstrom et al., Drugs, vol. 34, pp. 372-390 (1987).
Mitsuya et al., "Protection of T Cells against Infectivity and Cytopathic Effect of HTLV-III In Vitro Retroviruses in Human Lymphoma/Leukemia", Miwa et al. eds., VNU Science Press, Utrecht, 1985, pp. 277-288.
Altmann, "AIDS Epidemic Puts an Unusual Microbe Under Scrutiny", The N.Y. Times, New York, Jun. 26, 1990, p. C3.
Zamecnik et al., Proc. Nat. Acad. Sci. USA, vol. 83, pp. 4143-4146, 1986.

Affiliated with

Also associated with

Rating

Oligonucleotide phosphonates and method of inhibiting a human im does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotide phosphonates and method of inhibiting a human im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide phosphonates and method of inhibiting a human im will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1412521